Back to Feed
总结
据KSL等媒体报道，美国犹他州医疗系统Intermountain Health称，其面向家长和医护推动婴儿接种/使用RSV预防措施后，本季婴幼儿因呼吸道合胞病毒（RSV）住院明显下降。相关研究也指出，广泛使用单克隆抗体nirsevimab可显著降低新生儿与婴儿RSV住院风险。报道还称在宣传带动下，科罗拉多、蒙大拿和犹他等州婴儿防护覆盖率居全国前列，从而减轻医院压力并降低高风险儿童重症负担。
正文
RSV vaccination push made a huge difference for Utah's kids, Intermountain Health says KSL.com Universal nirsevimab slashes RSV infant hospitalizations, study suggests CIDRAP Colorado, Montana, and Utah Among Nation's Top States in RSV Protection for Babies Following Intermountain Health Awareness Effort Yahoo Finance Opinion: RSV Vaccine Vital to Missouri Children The Missouri Times Nirsevimab Linked to Lower RSV Hospitalization Risk in Newborns Infectious Disease Advisor
发布时间：